| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |